153 related articles for article (PubMed ID: 7778962)
1. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
Nelson KE; Vlahov D; Solomon L; Cohn S; Muñoz A
Arch Intern Med; 1995 Jun; 155(12):1305-11. PubMed ID: 7778962
[TBL] [Abstract][Full Text] [Related]
2. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
Nelson KE; Vlahov D; Galai N; Astemborski J; Solomon L
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S201-5. PubMed ID: 7865301
[TBL] [Abstract][Full Text] [Related]
3. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989.
Nicolosi A; Musicco M; Saracco A; Molinari S; Ziliani N; Lazzarin A
Epidemiology; 1990 Nov; 1(6):453-9. PubMed ID: 2090283
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
[TBL] [Abstract][Full Text] [Related]
7. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
8. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A
Arch Intern Med; 1994 Sep; 154(17):1971-6. PubMed ID: 8074601
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of drug users' compliance with zidovudine treatment.
Broers B; Morabia A; Hirschel B
Arch Intern Med; 1994 May; 154(10):1121-7. PubMed ID: 8185425
[TBL] [Abstract][Full Text] [Related]
11. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY.
el-Sadr W; Goetz RR; Sorrell S; Joseph M; Ehrhardt A; Gorman JM
Arch Intern Med; 1992 Aug; 152(8):1653-9. PubMed ID: 1353953
[TBL] [Abstract][Full Text] [Related]
13. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
[TBL] [Abstract][Full Text] [Related]
14. HIV-infection prevention messages for injecting drug users: sources of information and use of mass media--Baltimore, 1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Jul; 40(28):465-9. PubMed ID: 2062300
[TBL] [Abstract][Full Text] [Related]
15. Routine antepartum human immunodeficiency virus infection screening in an inner-city population.
Lindsay MK; Peterson HB; Feng TI; Slade BA; Willis S; Klein L
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):289-94. PubMed ID: 2761902
[TBL] [Abstract][Full Text] [Related]
16. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
Alcabes P; Muñoz A; Vlahov D; Friedland G
Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of HIV infection in drug users of Manipur.
Panda S; Kamei G; Pamei M; Sarkar S; Sarkar K; Singh ND; Deb BC
Natl Med J India; 1994; 7(6):267-9. PubMed ID: 7841877
[TBL] [Abstract][Full Text] [Related]
18. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
Williams AB; McNelly EA; Williams AE; D'Aquila RT
AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of infection by the human immunodeficiency virus type 1 in drug addicts in Madrid, over a 5 year period].
Sopelana P; Diéguez A; Bautista L
Med Clin (Barc); 1991 Nov; 97(16):601-3. PubMed ID: 1766279
[TBL] [Abstract][Full Text] [Related]
20. Routine human immunodeficiency virus infection screening of women requesting induced first-trimester abortion in an inner-city population.
Lindsay MK; Peterson HB; Taylor EB; Blunt M; Willis S; Klein L
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):347-50. PubMed ID: 2381611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
